Overall Fundamental outlook

Business Operations:

Sector: Consumer Defensive
Industry: Household & Personal Products

Emami Limited manufactures and markets personal and healthcare products in India and internationally. It provides ayurvedic antiseptic cream, prickly heat powder, doodh kesar body lotion, aloe neem lotion, vasocare herbal petroleum jelly, coconut oil, aloe vera gel, and hygiene products under the Boroplus brand; cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talc, and cool talc under the Navratna brand; and balm, balm ultra-power, quick relief roll-on, ortho vedic oil, ointment, relief gel and spray, healthcare products, pancharishta, nityam, and kesari jivan under the Zandu brand. The company also offers radiance cream and instant radiance face wash for men under the Fair and Handsome brand; haircare products and shampoo under the Kesh King brand; balm under the Mentho Plus brand; prickly heat powder under the Dermicool brand; hair oil, shampoos, and conditioners under the Emami 7 Oils in One brand; deodorants under the HE brand; hair colors under the Emami Diamond Shine brand; talc under the Emami Golden Beauty brand; herbal fairness cream under the Emami Naturally Fair brand; toothpaste under the Ayucare brand; hair colors and oils under the Emami Gold brand; and moisturisers, lotion, soft creams, glycerine creams and oils, petroleum jelly, baby shampoos, and other skin products under the Cream21 brand. Emami Limited was founded in 1974 and is headquartered in Kolkata, India.

Revenue projections:

Revenue projections for EMAMILTD
Revenue projections for EMAMILTD

With Emami Limited's revenues expected to fall below the previous year's, investors are likely to approach the stock with caution. Declining revenues can negatively affect profitability, which makes it harder for the company to maintain investor confidence and perform well in the market.

Financial Ratios:

currentRatio 0.000000
forwardPE 23.016054
debtToEquity 2.457000
earningsGrowth 0.146000
revenueGrowth 0.098000
grossMargins 0.682240
operatingMargins 0.294220
trailingEps 18.180000
forwardEps 20.837630

EMAMILTD's Forward PE is well-positioned, indicating the stock price is favorable compared to its earnings. This suggests the stock is not overpriced and offers room for growth, making it an attractive option for investors looking for future value appreciation.
Positive gross and operating margins for EMAMILTD highlight the company's profitability. These metrics reflect EMAMILTD's efficiency in controlling costs while generating strong revenue from its core operations, signaling robust financial health.
EMAMILTD's forward EPS surpassing its trailing EPS signals projected growth in profitability, with the company expected to perform better this year. This forecast suggests that EMAMILTD's earnings will improve compared to the previous financial year, highlighting optimism in its financial outlook.

Price projections:

Price projections for EMAMILTD
Price projections for EMAMILTD

Price projections for EMAMILTD have been revised lower over time, signaling a more cautious outlook from analysts. The gradual downward trend indicates that expectations for the company's growth may be softening.

Recommendation changes over time:

Recommendations trend for EMAMILTD
Recommendations trend for EMAMILTD


Analysts' buy bias toward EMAMILTD suggests the stock is seen as a solid investment, potentially motivating investors to consider it for their portfolios. With this positive outlook, EMAMILTD is likely to be viewed as a secure place to allocate funds, driving further interest in the stock.